Adcock Ingram Holdings | AIP - Selling And Administration Expenses


Adcock Ingram Holdings reported ZAR1.02B in Selling and Administration Expenses for its fiscal semester ending in June of 2025.



Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 585K 84K Sep/2025
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Life Healthcare ZAR 197M 76M Sep/2024
Moderna USD 308M 40M Dec/2025
Netcare ZAR 5.22B 399M Dec/2025
Organon & Co USD 399M 54M Sep/2025
Revvity USD 251.73M 9.82M Dec/2025
Tectonic Therapeutic USD 3.44M 1.52M Dec/2025
Viatris USD 1.03B 144.1M Dec/2025
Xeris Pharmaceuticals USD 42.64M 3.82M Dec/2025